Related by context. All words. (Click for frequent words.) 73 relapsed MM 72 R# #mg BID 70 serum phosphorous 70 CIMZIA ™ 70 azilsartan medoxomil 70 Index CDAI 70 RECIST Response Evaluation Criteria 70 ACR# ACR# 70 oxycodone CR 70 calculated creatinine clearance 70 Platelet counts 69 pharmacokinetic characteristics 69 hematological parameters 69 CANCIDAS 69 bepotastine besilate nasal spray 69 plus prednisone prednisolone 69 basal bolus regimen 69 fasting plasma glucose FPG 69 certolizumab 68 CTAP# Capsules 68 dose proportionality 68 Ceplene/IL-2 68 PASI scores 68 Non inferiority 68 dose proportional pharmacokinetics 68 mg BID dose 68 Cardiorespiratory fitness 68 infliximab monotherapy 68 Pharmacodynamic 68 Primary endpoints 68 pharmacokinetic PK profile 68 maximally tolerated dose 68 reduce serum phosphate 68 urinary N telopeptide 68 prednisone prednisolone plus 67 #mg dose [002] 67 morphometric vertebral fractures 67 pharmacodynamic profiles 67 alicaforsen enema 67 BENICAR HCT 67 desvenlafaxine succinate 67 HCV RESPOND 2 67 prospectively stratified 67 doxorubicin cyclophosphamide 67 Tumor Response 67 EDEMA3 trial 67 ARB telmisartan 67 epoetin alpha 67 pharmacodynamic parameters 67 ACR# responses 67 linear pharmacokinetics 67 ug kg 67 somatostatin analog 67 demonstrated clinically meaningful 67 tapentadol IR 67 Mg Uk 67 Cystatin C 67 Mg Usa 67 High Dose quadruples 67 viral kinetics 67 mg TID 67 8mg/kg 67 Crohn Disease Activity 67 angiographic outcomes 67 Pharmacokinetic 67 REMINYL ® 67 novel VDA molecule 67 anaphylactic reactions bronchospasm 66 glycosylated hemoglobin HbA1c 66 evaluating mipomersen 66 CYP#A# substrate 66 maximal tolerated 66 Tasigna prolongs 66 lactate dehydrogenase LDH 66 MoxDuo TM IR 66 #.#mg/dL 66 PegIFN RBV 66 PSMA ADC 66 CIMZIA TM 66 ONGLYZA saxagliptin 66 Xeloda ® 66 pegylated IFN 66 Cariprazine 66 See CLINICAL PHARMACOLOGY 66 q8h 66 teriflunomide 66 statin monotherapy 66 MARINOL R 66 Viral load 66 Munghana Lonene Listenership 66 Aeolus Pharmaceuticals Announces 66 enzyme immunoassay EIA 66 undetectable HBV DNA 66 trough FEV1 66 Budesonide foam crofelemer 66 alfa 2a 66 mcg BID 66 #mg BID [002] 66 Fasting blood glucose 66 ritonavir boosted atazanavir 66 baseline HbA1c 66 CYP#A# CYP#D# 66 urine albumin 65 ACTEMRA TM 65 dapagliflozin plus 65 GAMMAGARD 65 univariate 65 EOquin TM phase 65 echocardiographic parameters 65 Demonstrate Significant 65 HCV SPRINT 65 galiximab 65 mg RDEA# 65 lumbar spine BMD 65 Oral NKTR 65 Sanofi Pasteur Fluzone 65 serum cortisol 65 tipranavir r 65 CIMZIA R 65 hemagglutination inhibition HAI 65 Descriptive statistics 65 ratio ICER 65 TMC# r 65 Response Evaluation Criteria 65 genotypic resistance 65 HBeAg seroconversion 65 By JENNIFER LEARN 65 pharmacodynamic effects 65 IFN alfa 65 Univariate 65 NPH insulin 65 3mg/kg 65 mg eq 65 abacavir lamivudine 65 Symptom severity 65 Dispersants contain 65 serum urate 65 CCyR 65 recombinant PSMA vaccine 65 steroid dexamethasone 65 oral rivaroxaban 65 evaluating tivozanib 65 Targretin capsules 65 unfractionated heparin UFH 65 ORAL Solo 65 haematologic 65 Capacity FVC 65 ADCS CGIC 65 HICPs 65 fosamprenavir 65 bortezomib refractory 65 ribavirin RBV 65 plus prednisone 65 APTIVUS r 65 pegylated alpha interferon 65 μg kg 65 elevated ALT 65 aldosterone antagonist 65 torsemide ER 65 oxycodone IR 65 Teriflunomide 65 INSPIRE Trial Phase III 65 RECORD1 65 Tipranavir 65 cisplatin gemcitabine 65 naïve HCV 65 MAGE A3 ASCI 65 deCODE AF TM 65 Subgroup analyzes 65 SVR# 65 Thalomid ® 65 serum aminotransferase levels 65 ATACAND 65 trastuzumab emtansine T DM1 65 Solid Tumors criteria 65 hemostatic efficacy 65 O PPDS 65 mcg albinterferon alfa 2b 65 HER2 expression 65 Q#IR 65 hemagglutination inhibition 65 HOMA IR 65 Post hoc 65 OBPM 65 antiviral efficacy 65 PREZISTA r arm 65 #mg #mg #mg [003] 65 K ras mutations 65 TURBT 65 bevirimat Study 65 glomerular filtration 64 YONDELIS 64 ENMD # 64 TLUS 64 aminotransferases 64 dose escalation phase 64 DLTs 64 CTA# Injection 64 SYNERGY Stent 64 Halotron revenues 64 Techni lab 64 Platinol ® cisplatin 64 BENICAR 64 MCyR 64 HORIZONS AMI trial 64 pharmacodynamic properties 64 solid tumors ZYBRESTAT 64 XIENCE V PROMUS Stent 64 pharmacokinetic equivalence 64 cEVR 64 bezafibrate 64 dose pravastatin 64 Subgroup analysis 64 pharmacodynamic PD 64 GSK# [001] 64 tolerability profiles 64 PREZISTA r 64 MacroChem actual 64 multicenter multinational 64 endoscopic remission 64 -#.# log# 64 EDEMA4 trial 64 abnormal p# biomarker 64 SPRYCEL ® 64 interferon alfa 2b 64 definite stent thrombosis 64 preclinical efficacy 64 -#.# log# copies mL 64 #mg doses [002] 64 Oral Fingolimod 64 pharmacokinetic parameters 64 TIMP 1 64 Zemplar Capsules 64 demonstrated antitumor activity 64 Janis Joplin soundalike respiratory 64 maximal doses 64 NNT = 64 nalbuphine ER 64 Empatic ™ 64 biostatistical analysis 64 LEVAQUIN ® 64 brand ciclesonide HFA 64 CLARITY study 64 tapentadol ER 64 metabolite concentrations 64 lopinavir r arm 64 receiving INTRON 64 achieved CCyR 64 #mg/day [002] 64 venlafaxine XR 64 Acute Ischemic Stroke 64 administered subcutaneously 64 gemcitabine cisplatin 64 MGd 64 hematologic parameters 64 plasma kallikrein inhibitor 64 Androxal TM 64 ritonavir boosted 64 AAG geldanamycin analog 64 pyrexia mucositis sepsis febrile 64 Warfarin Coumadin 64 aspirin clopidogrel 64 epoetin beta 64 Anti Bacterial Envelope 64 COMPARATIVE FIGURES Certain 64 Rate ORR 64 irbesartan 64 sitaxsentan 64 postmenopausal osteoporotic women 64 NS5B polymerase 64 secondary efficacy endpoint 64 CINQUIL 64 Xelox 64 paliperidone ER 64 Secondary efficacy endpoints 64 vitamin B# folic acid 64 ISTA Pharmaceuticals Announces 64 Omacetaxine 64 aspartate aminotransferase AST 64 PORxin TM platforms 64 serum urate levels 64 ARCOXIA 64 moderate renal impairment 64 Angiographic 64 zotarolimus 64 LDH lactate dehydrogenase 64 serum clusterin levels 64 EBMT criteria 64 Hsp# Inhibitor 64 Telik Announces 64 CHAMPION PCI 64 plasma pharmacokinetics 64 oral levofloxacin 64 IFN α 64 vapreotide acetate 64 hyperinsulinemic euglycemic clamp 64 Fulvestrant 63 ARCALYST ® 63 bovine thrombin 63 dexamethasone Decadron 63 cerebral somatic oximeter 63 Severity MSCS score 63 riociguat 63 budesonide foam 63 zoledronate 63 FOLFOX6 chemotherapy regimen 63 ACR# response 63 oral hypoglycemic agent 63 statistical significance p 63 AST ALT 63 ACTOS ® 63 pharmacologically active isomer 63 QTcF 63 Darinaparsin 63 NSABP B 63 RE LY ® 63 clinically meaningful reductions 63 oral diclofenac 63 mL/min/#.# m 2 63 QTc prolongation 63 serum leptin 63 posttreatment 63 ALN HPN 63 DAS# remission 63 mg kg dose 63 hyperphenylalaninemia HPA due 63 Secondary endpoints include 63 Silver Eq 63 tolterodine ER 63 sustained virological response 63 unstable angina pectoris 63 DexaSite 63 mg kg BID 63 lispro 63 CYT# potent vascular disrupting 63 Known hypersensitivity 63 paroxetine sertraline 63 didanosine associated 63 PLX STROKE targeting 63 mg/m2 cohort 63 sUA 63 ULORIC 63 IV bisphosphonates 63 darbepoetin alfa 63 hemoglobin Hb 63 MERIT ES 63 cardiovascular calcification 63 Dabigatran etexilate 63 plus dexamethasone 63 gadobutrol 63 Brief Psychiatric 63 recurrent metastatic ovarian cancer 63 Creatinine 63 APTIVUS 63 Baseline characteristics 63 candesartan cilexetil 63 microgram kg 63 mcg QD 63 q#h 63 #mg q8h 63 Benazepril 63 Peginterferon Alfa 2a 63 Capsules CII 63 Kerastick ® 63 mg/m2 dose 63 topical gel formulation 63 Hamilton Anxiety Scale 63 HAQ DI 63 PEGINTRON TM 63 RECIST criteria 63 achieved ACR# 63 RSD# IV 63 EURIDIS 63 Telik logo TELINTRA 63 conditional logistic regression 63 animal xenograft models 63 antidepressants fluoxetine 63 CAPACITY trials 63 Fasting glucose 63 Bezielle 63 IMiDs ® 63 hsCRP levels 63 Folfox 63 specified secondary endpoints 63 REYATAZ r arm 63 Antitumor Activity 63 Analytical Protocols 63 IEQ kg 63 Rigel R# 63 HBeAg negative patients 63 salmeterol fluticasone 63 nicardipine 63 peginterferon alfa 63 spirometric 63 DEB# 63 Pegasys ® 63 paricalcitol 63 oxcarbazepine 63 fluvastatin 63 DAS# scores 63 colesevelam HCl 63 budesonide pMDI 63 microbiological eradication 63 xanthine oxidase inhibitor 63 Daptomycin 63 INVEGA ® 63 serum phosphate 63 LUCK Happy Birthday 63 CIMZIA TM certolizumab pegol 63 opioid naïve 63 ALT flares 63 ZOLINZA 63 Randomized Double blind 63 R rilonacept Injection 63 fluoxetine paroxetine 63 vitro cytotoxicity 63 quetiapine XR 63 UPDRS scores 63 multivariable logistic regression 63 docetaxel chemotherapy 63 FOLFOX6 63 dosage regimens 63 PDP MLR 63 titrated glipizide 63 Copegus ® 63 melphalan prednisone 63 gemcitabine carboplatin 63 fosbretabulin 63 preintervention 63 pomalidomide 63 Serious adverse reactions 63 CRESTOR #mg 63 Available Seat Kilometres ASKs 63 Negative Symptoms 63 EDARBI 63 5 Fluorouracil 63 oral FTY# 63 lanthanum carbonate 63 lopinavir r 63 Castration Resistant Prostate Cancer 63 Gastrointestinal Stromal Tumors 63 Danazol 63 quantitative coronary angiography 63 Pemetrexed 63 favorable pharmacokinetic profile 63 β blockers 63 postintervention 63 permanently discontinue Vectibix 63 trastuzumab Herceptin R 63 Hematologic toxicity 63 antiretroviral naïve 63 serum PTH 63 confidence intervals CIs 63 serum phosphate levels 63 postdose 63 efavirenz EFV 63 Peg IFN 63 verdict elicited gasps 63 limiting toxicity DLT 63 LAB CGRP 63 AirBoss Announces 63 -#.# mg dL [001] 63 clevidipine 63 ® bortezomib 63 follicular lymphomas 63 Plaque Psoriasis 63 #mg/m# [002] 63 zonisamide SR 63 serum lipid levels 63 lipid lowering agents 63 detectable HCV RNA 63 ER CHOP 62 kilogram mg kg 62 achieved statistical significance 62 nondiabetic patients 62 ara C 62 aspartate aminotransferase 62 cytarabine daunorubicin 62 -#.# mg dL [002] 62 By JENNIFER KOVACS 62 dose Iluvien 62 Montgomery Asberg Depression 62 vaccine RiVax TM 62 MERLIN TIMI 62 antiangiogenic activity 62 intraobserver 62 SSRI SNRI 62 6mg 62 Hycamtin ® 62 Cardiotoxicity 62 Tiffaney Utsman senior 62 seroprotection 62 NeuroSTAT ® 62 Am J Cardiol 62 mg BID 62 dosing cohort 62 ARIKACE 62 aplindore 62 Hum Mol Genet 62 serum HBV DNA 62 MoxDuo IR 62 Relapsed Multiple Myeloma 62 treatment naive genotype 62 Demonstrates Sustained 62 sorafenib Nexavar ® 62 Doxil ® 62 analgesic efficacy 62 FUSILEV enhances 62 urocortin 2 62 EDEMA3 62 efficacy endpoint 62 Triapine R 62 transaminases 62 SNALP formulations 62 EEG abnormalities 62 Temsirolimus 62 elotuzumab 62 DAS# CRP 62 zolmitriptan 62 culture supernatants 62 plasma creatinine 62 Hepatotoxicity 62 COMBIVIR 62 corticosteroid dose 62 estramustine 62 DOXIL 62 sorafenib tablets 62 daunorubicin 62 EGFr expressing metastatic colorectal 62 metabolic parameters 62 dizziness nausea diarrhea 62 Aztreonam lysine 62 Aptivus ® 62 VELCADE melphalan 62 pegylated interferon alfa 62 Cholinesterase Inhibitors 62 LymphoStat B belimumab 62 STRIDE PD 62 R brand eszopiclone 62 biologic DMARD 62 museum Julie Setlock 62 opioid naive 62 peripheral blood mononuclear 62 Randomized Phase II 62 CR nPR 62 adenosine injection 62 peg IFN 62 hemoglobin A1C HbA1C 62 Grouped Hockey 62 IV bolus 62 Crofelemer budesonide foam 62 Kahalalide F 62 interferon alfa 62 R ribavirin USP 62 prospective observational studies 62 Texas Instruments Narrows 62 Seliciclib 62 glittering dupatta scarves 62 ADCS ADL 62 FOREXYARD Daily Forex 62 CCX# 62 REVIVE TA 62 resected pancreatic cancer 62 Ambulatory Blood Pressure 62 Engerix B 62 luteinising hormone LH 62 bazedoxifene conjugated estrogens 62 macrolide antibiotic 62 timepoints 62 plasma HCV RNA 62 FOSRENOL ® 62 cinacalcet 62 hemoglobin A1c HbA1c 62 undetectable HCV RNA 62 apolipoprotein B 62 creatinine ratio 62 headache nasopharyngitis 62 Serum creatinine 62 HCV replicon 62 #-#,# mg 62 Vildagliptin 62 INTEGRILIN R eptifibatide Injection 62 Xanafide 62 multivariate Cox 62 Immunomedics Announces 62 baseline FEV 62 XL# anticancer compounds 62 Naive Patients 62 Solorel TM 62 virologic responses 62 ascending dose 62 PSADT 62 trastuzumab Herceptin ® 62 exhaled nitric oxide 62 orally administered inhibitor 62 telaprevir dosed 62 atazanavir ritonavir 62 plus Copegus R 62 statistically significant efficacy 62 mITT population 62 mg XP# 62 dalteparin 62 xenograft models 62 Aldean Shelton 62 PROCTOCORT ® Suppository Hydrocortisone 62 sargramostim 62 4mg/kg 62 IIIa inhibitor 62 DepoDur TM 62 CLIRS 62 An indigo twill 62 BARACLUDE ® 62 albiglutide 62 pegylated interferon alfa 2a 62 #mg/day [001] 62 IMiDs 62 Dialysis Outcomes 62 Inventory BPI 62 Vena Qualified Person 62 Pegasys plus Copegus 62 ALT elevation 62 lumbar spine bone 62 PREZISTA ritonavir 62 PegIFN 62 mg m² 62 metaglidasen 62 confirmed CCyR 62 Unfractionated Heparin 62 events SAEs 62 Bioequivalence 62 pharmacokinetics PK 62 FOLPI 62 CAMMS# 62 dopamine partial agonist 62 Kaplan Meier estimates 62 Moli# 62 Peginterferon 62 liposomal formulation 62 prasterone 62 novel orally inhaled 62 guanfacine extended release 62 PEGASYS ® 62 intermittent dosing 62 Meta analyzes 62 affective psychosis 62 Kaplan Meier analysis 62 Sensitivity analyzes 62 eNO 62 drug eluting stent implantation 62 ertapenem 62 rumpled dresser 62 Teduglutide proprietary analog 62 Introductory teaser rates 62 mitoxantrone plus 62 mediated dilation 62 PRADAXA #mg 62 MIC# [001] 62 chlorambucil 62 lipoprotein Lp 62 mg metformin 62 Emil Protalinski Published 62 Contrave# 62 Desvenlafaxine Succinate 62 scores TNSS 62 intravascular hemolysis 62 pegylated interferon alpha 62 Solid Tumors 62 warfarin sodium 62 SinuNase ™ 62 BARACLUDE R 62 Active Ulcerative Colitis 62 postoperative chemotherapy 62 multiple logistic regression 62 intravenous bolus 62 Evidence Therapeutic study 62 Fitch AAAmmf rating 62 weekly CSBMs 62 By EURSOC Two 62 PCI ExTRACT TIMI 62 storied chateau 62 NOAEL 62 alvespimycin 62 plasma renin activity 62 pharmacokinetic PK study 62 hole ESI# 62 erlotinib Tarceva ® 62 PITX2 methylation 62 limiting toxicity 62 ancrod 62 HIV RNA 62 Prescription acetaminophen 62 PCWP 62 Forages Cabo Inc. 62 NOXAFIL Oral Suspension 62 Evidence Therapeutic 62 CR CRu 62 pharmacokinetic PK 62 aminotransferase levels 62 Sustained virologic response 62 estimated GFR 62 Raptiva r 62 Fludara ® 62 IOP lowering 62 COPEGUS 62 NEVO ™ 62 mesalamine granules 62 BY RYAN BENTLEY 62 MADRS score 62 eszopiclone 62 sensitivity specificity 62 prospectively defined 62 KRAS status 62 5 FU leucovorin 62 #mg dosage strength 62 Hypertensive adverse reactions 62 biochemical relapse 62 tacrolimus ointment 62 inhaled budesonide 62 Paliperidone ER 62 complete cytogenetic response 62 glycated hemoglobin levels 62 active comparator 62 Elitek 62 intravesical infusion therapy 62 EOquin TM 62 Intravitreal 62 OGTT 62 Rigorous scientific 62 rFSH 62 Pharmacokinetic PK 62 + PH# 62 mGluR5 NAM 62 atorvastatin #mg 62 latrepirdine 62 Hb A1C 62 prespecified secondary 62 J Antimicrob Chemother 62 CrCl 62 lanreotide 62 Echocardiographic 62 Interrater reliability 62 baseline LDH 62 irinotecan cisplatin 62 Kosan proprietary 62 baseline serum creatinine 62 relapsed MCL 62 alpha 2A adrenoceptor 62 pegylated interferon alpha 2a 62 BRIM3 62 isotope dilution 62 Rivard MJ 61 mg simvastatin 61 PRIMO CABG2 61 PEG PAL 61 kilometers FTK 61 endothelin antagonists 61 fusion enhancers 61 Nambu theories permeate 61 albumin excretion rate 61 triglyceride TG 61 Val HeFT 61 Sandostatin ® 61 #rd Annual CTRC 61 Phase 2a IBS 61 evaluating REVLIMID 61 Lp PLA 2 61 Plasma concentrations 61 EXPAREL TM 61 exhaled NO 61 sapacitabine CYC# 61 Newly Diagnosed Multiple Myeloma 61 assaying protocols 61 Acetate Rectal Suppositories 61 multivariate regression analysis 61 Anti Tumor Activity 61 oral antidiabetic medication 61 Annualized ROE 61 Atkins dieters cardiovascular 61 Tesmilifene 61 Salix Pharmaceuticals Announces 61 Perifosine KRX 61 Kokoraleis convicted 61 HBeAg + 61 COPEGUS ribavirin 61 activated partial thromboplastin 61 response CCyR 61 hemodynamically significant 61 posaconazole 61 dipyridamole plus 61 CYPHER R Sirolimus Eluting 61 NCCTG N# 61 L PPDS 61 clinical trials XIFAXAN 61 LATUDA 61 RBD Palmolein FOB 61 EQUETRO 61 tranquilizers diazepam 61 pyrimidine nucleoside analog 61 liposomal doxorubicin 61 Ejection Fraction 61 Elevated triglycerides 61 LIALDA 61 LHRH antagonists 61 F FDG PET 61 mg q8h 61 HER2 overexpression 61 #mg QD [002] 61 Clin Chem 61 mg kg Hematide 61 Lipitor #mg 61 samalizumab 61 YY =Anders Ostergaard 61 3TC lamivudine 61 By ALEXANDER BURNS 61 glycated hemoglobin HbA1c 61 cytogenetic analyzes 61 DOI #.#/art.# 61 β carotene 61 TD perf 61 CYP#A# isoenzyme 61 pharmacokinetic profiles 61 Increlex R 61 μg dose 61 pharmacokinetic pharmacodynamic 61 dose dabigatran 61 massive sulphide ores 61 AMWO 61 Borrego Solar photovoltaic 61 Intravitreal injections 61 alanine aminotransferase 61 Dose Escalation 61 mg QD 61 hematologic toxicity 61 symptomatic VTE 61 SPRIX ® 61 amprenavir 61 unresectable HCC 61 RESIST studies 61 Virologic 61 clomipramine 61 Outpatient Setting 61 PEG IFN 61 logistic regression models 61 XP# Transported Prodrug 61 serotonin norepinephrine reuptake inhibitor 61 Alkeran 61 antiangiogenic therapy 61 mU liter 61 dosing cohorts 61 rhEPO 61 LMN cream 61 Candesartan 61 HIV coinfected 61 fractional shortening 61 XEPLION R 61 IV RSD# 61 acyclovir Lauriad R 61 AGILECT R 61 VIAject ™ 61 interferon gamma 1b 61 Maximum Tolerated Dose MTD 61 metformin sulfonylurea 61 LEXIVA r 61 pioglitazone HCl 61 Cipralex ® 61 9mg 61 MEND CABG 61 transaminase elevations 61 Secondary endpoints 61 Another Frenchwoman Veronique 61 Flowing tubing pressure 61 XP# XP# 61 mcg mL 61 AZT zidovudine Retrovir 61 Omacetaxine mepesuccinate 61 oxaliplatin Eloxatin 61 VCAM 1 61 pharmacodynamics PD 61 Indacaterol 61 glycosylated hemoglobin levels 61 tumor xenograft models 61 r hGH 61 meta regression 61 CCR5 receptor antagonist 61 ® emtricitabine 61 Severity Index PASI 61 left ventricular diastolic 61 Navarrete replaces 61 alemtuzumab treated 61 LifeVantage Announces 61 multivariable Cox 61 MYDICAR ® 61 corrected QT interval 61 Levels Linked 61 HMG CoA reductase inhibitors 61 imatinib therapy 61 Cotinine 61 BEXXAR Therapeutic Regimen 61 lenalidomide Revlimid R 61 Efficacy endpoints 61 relapsed myeloma 61 statistically significant superiority 61 serum lipid 61 treatment naïve genotype 61 TAXUS Stent 61 mineral density BMD 61 Muscular colt 61 INCB# [003] 61 CDAI score 61 metastatic HRPC 61 ABCSG 61 plus COPEGUS 61 pegylated liposomal doxorubicin 61 Naproxen sodium 61 #μg [002] 61 REGN# 61 Dementia Related Psychosis 61 insulin detemir 61 AEGR 61 Wrestling Wrap Up 61 Zometa hazard 61 IONSYS TM 61 moderate hepatic impairment 61 LV ejection fraction 61 anthracycline taxane 61 GLYX 61 Ann Oncol 61 mg p = 61 oral Hycamtin 61 Pegasys peginterferon alfa 2a 61 marketed pegylated interferons 61 CPAP adherence 61 BioFuel Announces 61 receiving prophylactic anticoagulation 61 Psoriasis Area 61 selective modulator 61 #mg/m# [001] 61 radiotherapy RT 61 RAPTIVA 61 Fireworks resounded 61 #.#mg/kg [002] 61 Lipstick Mystic Love 61 agonistic human 61 peginterferon alfa 2b 61 Lupuzor ™ 61 Refractory Hodgkin Lymphoma 61 Multivariate logistic regression 61 Bivalirudin 61 TO AVOID PREGNANCY WHILE 61 Myelosuppression 61 Natural Catastrophe Stress 61 isatoribine 61 Vidaza ® 61 serum estradiol 61 peg interferon 61 Poisson regression 61 oral picoplatin 61 virologic response 61 NMP# protein marker 61 blinded randomized placebo controlled 61 Dean Koontz Bantam FP 61 Genz # 61 mg/m2/day 61 busulfan 61 later Ettore Campogalliani 61 mg q#h 61 Gabriel Mollet 61 Kaydon Corporation Announces 61 hematopoietic cancers 61 balloon hem minidresses 61 intravenous dosing 61 intravesical therapy 61 mm Hg diastolic 61 Gadavist 61 radiation dosimetry 61 serum CRP 61 bortezomib Velcade R 61 sipuleucel T 61 Farfan Juan Pablo 61 bendamustine 61 AVOREN 61 Proellex TM 61 QT QTc 61 Stent thrombosis 61 Anika Therapeutics Reports 61 Metastatic Renal Cell Carcinoma 61 Albuminuria 61 hypophosphatemia 61 adjuvant GIST 61 serum potassium levels 61 Hormone Refractory Prostate Cancer 61 sulfonylurea metformin 61 Meets Primary Endpoint 61 Double Blind Randomized 61 intradermal injections 61 immunostaining 61 liver transaminases 61 virus HCV protease inhibitor 61 Antigen Specific